Article contents
Low infectivity among asymptomatic patients with a positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) admission test at a tertiary care center, 2020–2022
Published online by Cambridge University Press: 25 September 2023
Abstract
We used a strand-specific RT-qPCR to evaluate viral replication as a surrogate for infectiousness among 242 asymptomatic inpatients with a positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) admission test. Only 21 patients (9%) had detectable SARS-CoV-2 minus-strand RNA. Because most patients were found to be noninfectious, our findings support the suspension of asymptomatic admission testing.
- Type
- Concise Communication
- Information
- Copyright
- © The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Footnotes
a
Authors of equal contribution.
References
Larsen, CG, Bub, CD, Schaffler, BC, Walden, T, Intravia, JM. The impact of confirmed coronavirus disease 2019 (COVID-19) infection on ambulatory procedures and associated delays in care for asymptomatic patients. Surgery 2021;169:1340–1345.10.1016/j.surg.2021.01.005CrossRefGoogle ScholarPubMed
Bullard, J, Dust, K, Funk, D, et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis 2020;71:2663–2666.CrossRefGoogle ScholarPubMed
Singanayagam, A, Patel, M, Charlett, A, et al. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill 2020;25:2001483.CrossRefGoogle ScholarPubMed
Hogan, CA, Huang, C, Sahoo, MK, et al. Strand-specific reverse transcription PCR for detection of replicating SARS-CoV-2. Emerg Infect Dis 2021;27:632–635.CrossRefGoogle ScholarPubMed
Srinivasan, V, Gohil, SK, Abeles, SR, et al. Finding a needle in a haystack: the hidden costs of asymptomatic testing in a low incidence setting. Infect Control Hosp Epidemiol 2022;43:1525–1526.10.1017/ice.2021.288CrossRefGoogle Scholar
Adjei, S, Hong, K, Molinari, NM, et al. Mortality risk among patients hospitalized primarily for COVID-19 during the omicron and delta variant pandemic periods—United States, April 2020–June 2022. Morb Mortal Wkly Rep 2022;71:1182–1189.10.15585/mmwr.mm7137a4CrossRefGoogle Scholar
Azzolini, E, Levi, R, Sarti, R, et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in healthcare workers. JAMA 2022;328:676–678.10.1001/jama.2022.11691CrossRefGoogle ScholarPubMed
Xie, Y, Choi, T, and Al-Aly, Z. Nirmatrelvir and the risk of postacute sequelae of COVID-19. medRxiv 2022. doi: 10.1101/2022.11.03.22281783.Google Scholar
Talbot, TR, Hayden, MK, Yokoe, DS, et al. Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: challenges and considerations. Infect Control Hosp Epidemiol 2023;44:2–7.10.1017/ice.2022.295CrossRefGoogle ScholarPubMed
Alsuhaibani, MA, Kobayashi, T, Trannel, A. Coronavirus disease 2019 (COVID-19) admission screening and assessment of infectiousness at an academic medical center in Iowa, 2020. Infect Control Hosp Epidemiol 2022;43:974–978.10.1017/ice.2021.294CrossRefGoogle ScholarPubMed
- 4
- Cited by